Table 4.
ROC analysis of clinical risk assessment tools for Τ-score≤-2.0 and Τ-score>-2.0.
| AUC | SE | 95% CI | p-value | Cut-off point | Sensitivity | Specificity | PPV | NPV | ||
|---|---|---|---|---|---|---|---|---|---|---|
| SCORE* | 0.658 | 0.035 | 0.59 | 0.73 | <0.0005 | 8.5 | 64% | 56% | 43% | 75% |
| ORAI Score* | 0.652 | 0.037 | 0.58 | 0.72 | <0.005 | 9.0 | 63% | 63% | 47% | 76% |
| ABONE Score* | 0.603 | 0.038 | 0.53 | 0.68 | 0.007 | 1.5 | 43% | 78% | 50% | 72% |
| OST Score† | 0.673 | 0.034 | 0.61 | 0.74 | <0.005 | 1.05 | 50% | 75% | 51% | 74% |
| Osiris Score† | 0.680 | 0.034 | 0.61 | 0.75 | <0.005 | 1.50 | 55% | 70% | 48% | 75% |
| Osiris Adjusted Score† | 0.658 | 0.035 | 0.59 | 0.73 | <0.005 | 1.50 | 56% | 65% | 46% | 75% |
AUC: Area Under the Curve, SE: standard error, CI: confidence interval.
Larger values of the test result variable indicate stronger evidence for Τ-score≤-2.0.
Smaller values of the test result variable indicate stronger evidence for Τ-score≤-2.0.